Clinical Trials on Breast Neoplasm Malignant Female in Germany
Total 1338 results
-
iOMEDICO AGNovartis Pharmaceuticals; Arbeitsgemeinschaft fur Internistische OnkologieCompletedBreast Cancer Recurrent | HER2/Neu-negative Carcinoma of Breast | Hormone Receptor Positive Malignant Neoplasm of BreastGermany
-
Pulsion Medical Systems SEUnknownMalignant Neoplasm of BreastGermany
-
Institut fuer FrauengesundheitMerck Sharp & Dohme LLC; Celgene CorporationCompletedMalignant Neoplasm of BreastGermany
-
Institut fuer FrauengesundheitMerck Sharp & Dohme LLCActive, not recruitingBreast Cancer | Malignant Neoplasm of BreastGermany
-
Institut fuer FrauengesundheitEisai GmbHRecruitingAssessing ImmunoResponse Post Eribulin: Eribulin and Immunogenicity in Advanced Breast Cancer (AIRE)Breast Cancer Female | Breast Cancer Metastatic | Neoplasm, BreastGermany
-
Novian Health Inc.RecruitingMalignant Neoplasm of BreastSwitzerland, United States, Germany
-
AryoGen Pharmed Co.CompletedMalignant Neoplasm of BreastIran, Islamic Republic of
-
International Research Training Group 2804German Research Foundation; Uppsala University; University Hospital TuebingenNot yet recruitingMenopause | Breast Cancer Female | Healthy Female | Anti-estrogenic TherapyGermany
-
Technical University of MunichUnknownHeart Diseases | Breast Neoplasm Female | Radiotherapy Side EffectGermany
-
University of JenaCompleted
-
Rna Diagnostics Inc.RecruitingBreast Neoplasm FemaleGermany, United States, Canada, France, Italy, Spain, Poland
-
University Hospital, EssenCompleted
-
Philipps University Marburg Medical CenterUniversitätsklinikum Hamburg-Eppendorf; University of Hamburg-EppendorfUnknownFemale Breast CancerGermany
-
Philipps University Marburg Medical CenterUnknownFemale Breast CancerGermany
-
Institut fuer FrauengesundheitNovartis Pharmaceuticals; AGO Breast Study Group e.V.RecruitingBreast Cancer | Breast Neoplasms | Advanced Breast Cancer | Breast Neoplasm Female | Breast Cancer Female | HER2-negative Breast Cancer | Hormone Receptor-positive Breast CancerGermany
-
University Hospital TuebingenRecruitingBreast Cancer FemaleGermany
-
Institut de Radioprotection et de Surete NucleaireInstitut Català d'Oncologia; Technical University of Munich; Hospital de Santa... and other collaboratorsCompletedBreast Cancer FemaleSpain, Germany, France, Netherlands, Portugal
-
German Breast GroupPfizerCompletedMale Breast CancerGermany
-
German Breast GroupCelgene Corporation; AmgenCompletedInflammatory Breast Cancer | HER2 Positive Breast Cancer | Tubular Breast Cancer Stage II | Mucinous Breast Cancer Stage II | Breast Cancer Female NOS | Invasive Ductal Breast Cancer | Tubular Breast Cancer Stage IIIGermany
-
ExelixisActive, not recruitingA Study of XL092 as Single-Agent and Combination Therapy in Subjects With Solid Tumors (STELLAR-001)Renal Cell Carcinoma | Colorectal Cancer | Metastatic Castration-resistant Prostate Cancer | Hormone Receptor Positive Breast Carcinoma | Neoplasm MalignantUnited States, Australia, Belgium, Czechia, France, Germany, Italy, Netherlands, Spain, United Kingdom
-
Charite University, Berlin, GermanyGerman Cancer AidCompletedMalignant Neoplasm of Stomach | Secondary Malignant Neoplasm of Peritoneum | Secondary Malignant Neoplasm of Other and Unspecified SitesGermany
-
Prof. Dr. med. Christian GratzkeMerck Sharp & Dohme LLCRecruitingUrologic Cancer | Biochemical Recurrence of Malignant Neoplasm of ProstateGermany
-
German Breast GroupRoche Pharma AG; Celgene CorporationCompletedInflammatory Breast Cancer | HER-2 Positive Breast Cancer | Tubular Breast Cancer Stage II | Mucinous Breast Cancer Stage II | Breast Cancer Female NOS | Invasive Ductal Breast Cancer | Tubular Breast Cancer Stage III | Inflammatory Breast Cancer Stage IVGermany
-
Prof. Wolfgang JanniCompletedHER2-negative and Hormone-receptor Positive Metastatic Breast Cancer | HER2-negative Circulating Tumor Cells | Postmenopausal Female PatientsGermany
-
Heidelberg UniversityUnknownUterine Cervical Neoplasms | Endometrial Neoplasms MalignantGermany
-
German Breast GroupRoche Pharma AG; Amgen; Teva Pharmaceuticals USA; Vifor PharmaCompletedInflammatory Breast Cancer | HER2 Positive Breast Cancer | Tubular Breast Cancer Stage II | Mucinous Breast Cancer Stage II | Breast Cancer Female NOS | Invasive Ductal Breast Cancer | Tubular Breast Cancer Stage IIIGermany
-
University Hospital Schleswig-HolsteinZealand University HospitalNot yet recruitingBreast Cancer FemaleGermany
-
Institut fuer FrauengesundheitSamsung Bioepis Co., Ltd.RecruitingBreast Cancer | Breast Neoplasms | HER2-positive Breast Cancer | Breast Cancer FemaleGermany
-
Technical University of MunichCompletedHereditary Breast and Ovarian CancerGermany
-
Dr. Horst Schmidt Klinik GmbHDeutsche Gesellschaft für hypnose und hypnotherapie E.V.TerminatedBreast Neoplasm | Ovary CancerGermany
-
Translational Research in OncologyBayerCompletedBreast Cancer FemaleGermany, Canada, United States
-
Toralf Reimer, MD PhDEuropean Breast Cancer Reseach Association of Surgical Trialists; University... and other collaboratorsRecruitingBreast Cancer | Breast Cancer FemaleSpain, Austria, Germany, Italy
-
Hologic, Inc.CompletedBreast Cancer FemaleNetherlands, France, Germany, Italy, Spain, United Kingdom
-
German Breast GroupGlaxoSmithKline; Roche Pharma AG; Teva Pharmaceuticals USACompletedInflammatory Breast Cancer | HER-2 Positive Breast Cancer | Tubular Breast Cancer Stage II | Mucinous Breast Cancer Stage II | Breast Cancer Female NOS | Invasive Ductal Breast Cancer | Tubular Breast Cancer Stage III | Inflammatory Breast Cancer Stage IVGermany
-
SanofiSOLTI Breast Cancer Research GroupCompletedBreast Cancer FemaleSpain, France, Germany
-
Palleos Healthcare GmbHPfizer; Cankado GmbH; WSG WOMEN´S HEALTHCARE STUDY GROUP; AGO-TraFo; AGO-B; Deutsche...Terminated
-
West German Study GroupAgendiaRecruitingFemale Breast CancerGermany
-
Boehringer IngelheimCompletedMalignant Solid TumourGermany
-
Universität Duisburg-EssenKarl and Veronica Carstens FoundationCompletedBreast NeoplasmGermany
-
NovartisTerminatedBreast Cancer With Bone MetastasisGermany
-
West German Study GroupEli Lilly and Company; Genomic Health®, Inc.RecruitingBreast Cancer FemaleGermany
-
West German Study GroupNovartis; Genomic Health®, Inc.Recruiting
-
Universitätsklinikum Hamburg-EppendorfRecruitingCarcinoma | Palliative Care | Malignant NeoplasmGermany
-
Palleos Healthcare GmbHRoche Pharma AG; University Hospital, Essen; University Hospital Erlangen; Phaon...Active, not recruitingTriple-negative Breast CancerGermany
-
Heidelberg UniversityCompleted
-
West German Study GroupCelgeneActive, not recruiting
-
AstraZenecaTerminatedBreast NeoplasmKorea, Republic of, Germany, Taiwan
-
University Hospital TuebingenCompletedLocoregional Metastases in Malignant Melanoma Stages IIIB/CGermany
-
German Breast GroupNovartisUnknown